This finding may provide a novel cellular and molecular mechanism for the involvement of ERVWE1 in the etiology of schizophrenia and open new possibilities for drug development targeting ERVWE1 and ALKBH5 to treat schizophrenia patients (Fig. 9). This evidence concerns the gene ALKBH5 and schizophrenia.